BDNF and Mental deterioration: Most studies to date, however, have been performed on patients with specific neuropsychiatric disorders and chronic diseases (Williams et al., 2017; Du et al., 2019; Jiang et al., 2019), and data from prospective studies associating circulating BDNF with a subsequent decline in overall or subdomain-specific cognitive decline in the broad community-dwelling older population remain scarce.